Pulmonary Vein News and Research

RSS

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Adding digital twin-guided ablation to a standard ablation technique improved outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Ablation methods equally effective for drug-resistant paroxysmal atrial fibrillation

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking trial presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Cryoablation for PFO closure in AF patients undergoing PVI

New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing pulmonary vein isolation (PVI) in a single procedure.

27 Nov 2024

Study finds no added benefit of extensive ablation for persistent atrial fibrillation

In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in other areas of the heart.

2 Sep 2024

Catheter ablation proven effective for atrial fibrillation in new study

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements in symptoms and quality of life compared with a sham (placebo) procedure, according to late breaking research presented in a Hot Line Session at this year's ESC Congress 2024 in London, UK (30 Aug - 2 Sept).

2 Sep 2024

AI enhances understanding of radiation-induced cardiac arrhythmia risk in lung cancer patients

Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have used artificial intelligence tools to accelerate the understanding of the risk of specific cardiac arrhythmias when various parts of the heart are exposed to different thresholds of radiation as part of a treatment plan for lung cancer.

27 Aug 2024

AI tools accelerate understanding of cardiac arrhythmia risks in lung cancer treatment

Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, have used artificial intelligence tools to accelerate the understanding of the risk of specific cardiac arrhythmias when various parts of the heart are exposed to different thresholds of radiation as part of a treatment plan for lung cancer.

20 Aug 2024

Mayo Clinic pioneers use of pulsed field ablation to treat atrial fibrillation

Cardiologists in Mayo Clinic's Heart Rhythm Clinic are using a new innovative energy source to safely and successfully treat a common type of heart arrhythmia.

13 Aug 2024

First-ever successful use of modified double-decker technique for scimitar syndrome in a child

Scimitar syndrome, a rare congenital heart disease, involves an anomalous pulmonary venous return where the right pulmonary veins return to the inferior vena cava instead of the left atrium.

18 Jul 2024

Study shows safety of pulsed field ablation for treating patients with atrial fibrillation

Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF), according to the largest study of its kind on this new technology, led by the Icahn School of Medicine at Mount Sinai.

8 Jul 2024

Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

20 May 2024

Experts recommend shortening the blanking period after atrial fibrillation ablation

New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.

17 Apr 2024

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort.

8 Jan 2024

Pulsed field ablation safe and effective for women with atrial fibrillation

Women with atrial fibrillation (AF) undergoing a procedure called pulsed field ablation (PFA) have just as good outcomes as men with AF undergoing the same procedure, according to a large-scale international study led by the Icahn School of Medicine at Mount Sinai.

1 Nov 2023

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

MRI-guided ablation improves outcomes for younger AFib patients, study shows

Younger atrial fibrillation (AFib) patients are most likely to benefit from more personalized, MRI-guided ablation treatments to correct irregular heart rhythms, according to a new artificial intelligence-guided analysis of results from the DECAAF II trial, one of the largest global studies of treatments for heart arrhythmias.

25 Aug 2023

Innovative three-step ablation approach holds promise for patients with persistent atrial fibrillation

An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation compared to pulmonary vein isolation (PVI) alone, according to late-breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.

18 Apr 2023

Extended ECG monitoring of patients with hypertrophic cardiomyopathy detects more arrhythmias

Thirty day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.

17 Apr 2023

Updated expert consensus statement on transcatheter left atrial appendage closure released

Today, the Society for Cardiovascular Angiography & Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure (LAAC).

27 Mar 2023

Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.

From Biosense Webster Inc. 17 Oct 2022